Aclaris Therapeutics Statistics
Total Valuation
ACRS has a market cap or net worth of $135.35 million. The enterprise value is -$65.95 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACRS has 108.28 million shares outstanding. The number of shares has increased by 27.19% in one year.
| Current Share Class | 108.28M |
| Shares Outstanding | 108.28M |
| Shares Change (YoY) | +27.19% |
| Shares Change (QoQ) | +28.42% |
| Owned by Insiders (%) | 2.67% |
| Owned by Institutions (%) | 46.94% |
| Float | 60.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.34 |
| Forward PS | 26.09 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -22.30% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $277,766 |
| Profits Per Employee | -$2.03M |
| Employee Count | 64 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.84% in the last 52 weeks. The beta is 0.43, so ACRS's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +6.84% |
| 50-Day Moving Average | 1.44 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 42.97 |
| Average Volume (20 Days) | 740,626 |
Short Selling Information
The latest short interest is 4.45 million, so 4.11% of the outstanding shares have been sold short.
| Short Interest | 4.45M |
| Short Previous Month | 4.07M |
| Short % of Shares Out | 4.11% |
| Short % of Float | 7.30% |
| Short Ratio (days to cover) | 3.78 |
Income Statement
In the last 12 months, ACRS had revenue of $17.78 million and -$130.21 million in losses. Loss per share was -$1.44.
| Revenue | 17.78M |
| Gross Profit | -30.94M |
| Operating Income | -54.18M |
| Pretax Income | -59.05M |
| Net Income | -130.21M |
| EBITDA | -53.94M |
| EBIT | -54.18M |
| Loss Per Share | -$1.44 |
Full Income StatementBalance Sheet
The company has $113.59 million in cash and $2.60 million in debt, giving a net cash position of $201.30 million or $1.86 per share.
| Cash & Cash Equivalents | 113.59M |
| Total Debt | 2.60M |
| Net Cash | 201.30M |
| Net Cash Per Share | $1.86 |
| Equity (Book Value) | 155.55M |
| Book Value Per Share | 1.44 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | -174.06% |
| Operating Margin | -304.78% |
| Pretax Margin | -732.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |